Short answer
Anterix Inc. (ATEX) filed its Q3 2026 10-Q quarterly report on Nov 10, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $2M (up 26.2% year over year) with net income of −$5M.
Q3 2026 key financials · XBRL
- Revenue
- $2M
- +26.2% YoY · +0.0% QoQ
- Net income
- −$5M
- −109.3% YoY · −2180.4% QoQ
- Operating margin
- -291.6%
- EPS (diluted)
- −$0.26
- −109.1% YoY · −2700.0% QoQ
Source: XBRL data from the Anterix Inc. (ATEX) Q3 2026 10-Q on SEC EDGAR. USD.
Anterix Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $2.0M, up 26% YoY from $1.6M, driven by TECO license delivery
- Net loss $5.0M vs net income $53.5M YoY, reflecting lower intangible-asset gains
- Spectrum revenue best-performing line, $2.0M vs $1.6M; no segment data disclosed
- Cash and equivalents $107.5M; six-month operating cash use $4.1M vs $1.7M
- Capital deployment: $12.2M investing outflow, $22.2M financing inflow from $23.2M option exercises
- Outlook: liquidity sufficient for at least 12 months, with potential additional capital needs and regulatory headwinds
Risk Factors
- No material changes from the 2026 Annual Report’s disclosed risk factors
- Unknown or currently immaterial risks could adversely affect results of operations or financial condition
- Undisclosed carried-forward risks may materially affect Anterix’s common stock valuation
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Anterix Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.